시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 파제트병 치료 시장 보고서(2025년)
Paget Disease Treatment Global Market Report 2025
상품코드 : 1730980
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,312,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,124,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 11,936,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 파제트병 치료 시장 규모는 향후 수년간 안정된 성장이 예상될 예정입니다. 예측 기간 중 성장은 표적요법에 대한 수요 증가, 헬스케어 지출 증가, 고령화 인구 증가, 신규 요법의 임상시험 증가, 맞춤형 의료에 대한 주목 증가 등에 기인한다고 생각됩니다.

관절염의 증례 수와 뼈 손상 증가는 파제트병 치료 시장의 성장을 가속할 것으로 예측됩니다. 이러한 질환의 증가는 운동부족과 연관되어 있으며, 근육과 관절을 약화시켜 움직임을 보조하고 충격을 흡수하는 능력을 저하시킵니다. 그 결과, 시간의 경과와 함께 관절의 변성, 경직, 골절의 리스크가 높아집니다. 예를 들어 2024년 2월 미국을 거점으로 하는 공중위생기관인 질병대책예방센터(CDC)는 2022년 18세 이상의 성인의 진단된 관절염의 연령조정유병률은 18.9%로 남성(16.1%) 또한 여성(21.5%)이 더 높은 발병률을 보였습니다고 보고했습니다.

파제트병 치료 시장의 각 회사는 치료 효과의 향상, 환자 결과의 개선, 시장에서의 프레즌스 확대를 위해 칼슘 조정제 등의 혁신적인 제품의 개발에 주력하고 있습니다. 칼슘 조절제는 혈액과 뼈의 칼슘 농도를 조절하고 다양한 생리 기능을 지원하는 균형을 유지하는 데 도움이되는 약물과 물질입니다. 예를 들어, 2025년 2월 독일의 건강 관리 기업인 Fresenius Kabi AG는 증후성 골파제트병, 고칼슘혈증, 폐경 후 골다공증 치료를 목적으로 하는 칼슘 조절제인 Calcitonin Salmon Injection USP Synthetic을 출시했습니다. 이번 출시는 보다 비용 효율적인 치료 옵션을 제공하고, 공급망을 강화하고, 제너릭 주사제의 포트폴리오를 확대하는 것을 목적으로 하고 있습니다. Fresenius Kabi는 또한 필수적인 의약품의 안정적인 공급을 보장하기 위해 시설에 대규모 투자를 실시하고 있으며, 환자 케어의 향상과 리딩 헬스 케어 프로바이더로서의 지위의 확립을 목표로 하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

JHS
영문 목차

영문목차

Paget's disease is a chronic bone disorder marked by abnormal bone remodeling, which leads to weakened and enlarged bones. Treatment generally includes medications to regulate bone metabolism and manage symptoms, pain relievers, and, in some cases, surgery to address severe bone deformities.

The primary treatments for Paget's disease include Actonel, Reclast, Zoledronic acid, Fosamax, Miacalcin, Aredia, Calcitonin, Zometa, and other therapies. Actonel is a brand name for risedronate, a medication used to treat and prevent osteoporosis by strengthening bones. These treatments are administered through various routes, such as oral, intravenous, and topical, and are distributed via different channels, including hospital pharmacies, retail pharmacies, online pharmacies, and drug stores. The key end users of these treatments are hospitals, clinics, and other healthcare providers.

The paget disease treatment market research report is one of a series of new reports from The Business Research Company that provides paget disease treatment market statistics, including the paget disease treatment industry global market size, regional shares, competitors with the paget disease treatment market share, detailed paget disease treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the paget disease treatment industry. This paget disease treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The paget disease treatment market size has grown steadily in recent years. It will grow from $2.12 billion in 2024 to $2.21 billion in 2025 at a compound annual growth rate (CAGR) of 4.1%. The growth during the historic period can be attributed to the rising prevalence of Paget's disease, increased awareness and diagnosis rates, an aging population, the expansion of healthcare infrastructure, and the growing adoption of bisphosphonates.

The paget disease market size is expected to see steady growth in the next few years. It will grow to $2.57 billion in 2029 at a compound annual growth rate (CAGR) of 3.9%. The growth during the forecast period can be attributed to the rising demand for targeted therapies, increasing healthcare expenditure, a growing aging population, more clinical trials for novel therapies, and a greater focus on personalized medicine. Key trends during this period include advancements in treatment options, a shift toward biologic treatments, the development of combination therapies, the integration of digital health solutions, and progress in diagnostic technologies.

The growing number of arthritis cases and bone injuries is expected to drive the growth of the Paget disease treatment market. Arthritis is a condition that causes joint inflammation, while bone injuries can also contribute to its development. The rise in these conditions is linked to physical inactivity, which weakens muscles and joints, reducing their ability to support movement and absorb impact. This leads to an increased risk of joint degeneration, stiffness, and fractures over time. Paget disease treatment plays a crucial role in managing arthritis and bone injuries by alleviating bone pain, improving joint function, and preventing complications such as fractures and deformities caused by abnormal bone remodeling. For example, in February 2024, the Centers for Disease Control and Prevention (CDC), a U.S.-based public health institute, reported that in 2022, the age-adjusted prevalence of diagnosed arthritis among adults aged 18 and older was 18.9%, with women (21.5%) showing a higher incidence than men (16.1%). The prevalence of arthritis increases with age, ranging from 3.6% in individuals aged 18-34 to 53.9% in those aged 75 and older. This rise in arthritis and bone injuries is driving the demand for Paget disease treatments.

Companies in the Paget disease treatment market are focusing on developing innovative products, such as calcium regulators, to improve treatment efficacy, enhance patient outcomes, and expand their market presence. A calcium regulator is a medication or substance that helps control calcium levels in the blood and bones, maintaining balance to support various physiological functions. For example, in February 2025, Fresenius Kabi AG, a Germany-based healthcare company, introduced Calcitonin Salmon Injection, USP Synthetic, a calcium regulator designed to treat symptomatic Paget's disease of the bone, hypercalcemia, and postmenopausal osteoporosis. This launch aims to provide a more cost-effective treatment option, strengthen their supply chain, and expand their portfolio of generic injectables. Fresenius Kabi has also invested significantly in its facilities to ensure a steady supply of essential medicines, aiming to enhance patient care and solidify its position as a leading healthcare provider.

In June 2024, Sun Pharmaceutical Industries Limited, an India-based pharmaceutical company, acquired Taro Pharmaceutical for approximately $347.73 million. This acquisition was intended to give Sun Pharma full control of Taro Pharmaceutical Industries Ltd., boosting its dermatology and specialty generics portfolio while streamlining operations and maximizing synergies. Taro Pharmaceutical Industries Ltd., an Israel-based company, specializes in generic and specialty medicines, including treatments for Paget's disease.

Major players in the paget disease treatment market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Novartis AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Mylan N.V., Fresenius Kabi AG, Zimmer Biomet Holdings Inc., Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Apotex Inc., Sumitomo Pharma Co. Ltd., Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Cipla Limited, Endo International plc, Zaklady Farmaceutyczne Polpharma S.A., Abiogen Pharma S.p.A.

North America was the largest region in the paget disease treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in paget disease treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the paget disease treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The paget disease treatment market consists of revenues earned by entities by providing services such as diagnosis services, orthopedic services, genetic counseling services, and follow-up and monitoring services. The market value includes the value of related goods sold by the service provider or included within the service offering. The paget disease treatment market also includes sales of pain management medications, calcium and vitamin D supplements, bone density monitoring devices, and assistive devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Paget Disease Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on paget disease treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for paget disease treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The paget disease treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Paget Disease Treatment Market Characteristics

3. Paget Disease Treatment Market Trends And Strategies

4. Paget Disease Treatment Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Paget Disease Treatment Growth Analysis And Strategic Analysis Framework

6. Paget Disease Treatment Market Segmentation

7. Paget Disease Treatment Market Regional And Country Analysis

8. Asia-Pacific Paget Disease Treatment Market

9. China Paget Disease Treatment Market

10. India Paget Disease Treatment Market

11. Japan Paget Disease Treatment Market

12. Australia Paget Disease Treatment Market

13. Indonesia Paget Disease Treatment Market

14. South Korea Paget Disease Treatment Market

15. Western Europe Paget Disease Treatment Market

16. UK Paget Disease Treatment Market

17. Germany Paget Disease Treatment Market

18. France Paget Disease Treatment Market

19. Italy Paget Disease Treatment Market

20. Spain Paget Disease Treatment Market

21. Eastern Europe Paget Disease Treatment Market

22. Russia Paget Disease Treatment Market

23. North America Paget Disease Treatment Market

24. USA Paget Disease Treatment Market

25. Canada Paget Disease Treatment Market

26. South America Paget Disease Treatment Market

27. Brazil Paget Disease Treatment Market

28. Middle East Paget Disease Treatment Market

29. Africa Paget Disease Treatment Market

30. Paget Disease Treatment Market Competitive Landscape And Company Profiles

31. Paget Disease Treatment Market Other Major And Innovative Companies

32. Global Paget Disease Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Paget Disease Treatment Market

34. Recent Developments In The Paget Disease Treatment Market

35. Paget Disease Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기